Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a22ab3c14ae8f162

Jump to content

// Workers AI · dad joke modeWhat did MS15203 say to MS15204? Let's sync up.

From Wikipedia, the free encyclopedia

MS15203
Identifiers
  • 5-(2-methylprop-2-enoylamino)benzene-1,3-dicarboxylic acid
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H11NO5
Molar mass249.222 g·mol−1
3D model (JSmol)
  • CC(=C)C(=O)NC1=CC(=CC(=C1)C(=O)O)C(=O)O
  • InChI=1S/C12H11NO5/c1-6(2)10(14)13-9-4-7(11(15)16)3-8(5-9)12(17)18/h3-5H,1H2,2H3,(H,13,14)(H,15,16)(H,17,18)
  • Key:NVOBVSWSDYFEMR-UHFFFAOYSA-N

MS15203 (5-Methacrylamidoisophthalic acid) is an experimental drug which acts as a selective agonist for the neuropeptide receptor GPR171. In studies on mice it increases food intake and has analgesic effects, but shows sex-selective activity with greater effects in male mice than in female mice.[1][2][3]

References

[edit]
  1. Wardman JH, Gomes I, Bobeck EN, Stockert JA, Kapoor A, Bisignano P, et al. (May 2016). "Identification of a small-molecule ligand that activates the neuropeptide receptor GPR171 and increases food intake". Science Signaling. 9 (430): ra55. doi:10.1126/scisignal.aac8035. PMC 5150984. PMID 27245612.
  2. Ram A, Edwards T, McCarty A, Afrose L, McDermott MV, Bobeck EN (2021). "GPR171 Agonist Reduces Chronic Neuropathic and Inflammatory Pain in Male, But Not Female Mice". Frontiers in Pain Research. 2 695396. Lausanne, Switzerland. doi:10.3389/fpain.2021.695396. PMC 8915562. PMID 35295419.
  3. McDermott MV, Ram A, Mattoon MT, Haderlie EE, Raddatz MC, Thomason MK, et al. (March 2023). "A small molecule ligand for the novel pain target, GPR171, produces minimal reward in mice". Pharmacology, Biochemistry, and Behavior. 224 173543. doi:10.1016/j.pbb.2023.173543. PMC 11472835. PMID 36933620.